Takeda Pharmaceutical Company Limited Share Price London S.E.
Equities
0A87
US8740602052
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.07 USD | +0.12% | +0.11% | -8.12% |
06-06 | Former Takeda Employee Pleads Guilty to Defrauding Company | DJ |
06-06 | Takeda Pharmaceutical Unit Partners with HEALWELL AI for Real-World Evidence Analysis of Hereditary Angioedema | MT |
Sales 2024 | 4,264B 27.45B 2,147B | Sales 2025 * | 4,252B 27.37B 2,141B | Capitalization | 6,594B 42.45B 3,320B |
---|---|---|---|---|---|
Net income 2024 | 144B 927M 72.54B | Net income 2025 * | 116B 750M 58.63B | EV / Sales 2024 | 1.54 x |
Net Debt 2024 * | 3,771B 24.27B 1,899B | Net Debt 2025 * | 4,224B 27.19B 2,127B | EV / Sales 2025 * | 2.54 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
59.6
x | Employees | 49,095 |
Yield 2024 |
4.49% | Yield 2025 * |
4.61% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 day | +0.12% | ||
1 week | +0.11% | ||
Current month | -1.69% | ||
1 month | -2.09% | ||
3 months | -11.03% | ||
6 months | -6.45% | ||
Current year | -8.12% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 31/03/14 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 31/01/22 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 31/12/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 31/05/16 | |
Ian Clark
BRD | Director/Board Member | 62 | 31/12/18 |
Steven Gillis
BRD | Director/Board Member | 71 | 31/12/18 |
Date | Price | Change | Volume |
---|---|---|---|
06/06/24 | 13.49 | -0.07% | 1,958 |
05/06/24 | 13.5 | +0.82% | 391 |
04/06/24 | 13.39 | -0.52% | 599 |
03/06/24 | 13.46 | +1.24% | 416 |
31/05/24 | 13.3 | +1.84% | 1,654 |
Delayed Quote London S.E., May 23, 2024 at 03:28 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.64% | 754B | |
+39.42% | 630B | |
-6.58% | 352B | |
+19.72% | 331B | |
+8.78% | 298B | |
+11.92% | 217B | |
-2.62% | 216B | |
+0.03% | 163B | |
+6.13% | 164B |
- Stock Market
- Equities
- 4502 Stock
- 0A87 Stock